| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 292.178 | 312.746 | 156.214 | 114.192 | 163.400 | 193.906 | 235.875 | 270.425 | 255.759 | 299.402 |
| Total Income - EUR | 318.032 | 327.023 | 158.931 | 118.514 | 163.822 | 194.869 | 236.921 | 271.716 | 256.360 | 299.971 |
| Total Expenses - EUR | 304.894 | 307.028 | 167.900 | 121.941 | 146.274 | 175.918 | 203.639 | 242.908 | 233.980 | 313.276 |
| Gross Profit/Loss - EUR | 13.138 | 19.995 | -8.969 | -3.427 | 17.548 | 18.950 | 33.282 | 28.807 | 22.380 | -13.304 |
| Net Profit/Loss - EUR | 12.482 | 14.779 | -12.829 | -4.612 | 15.909 | 17.297 | 31.197 | 26.145 | 20.124 | -13.304 |
| Employees | 8 | 8 | 6 | 4 | 3 | 3 | 3 | 3 | 3 | 5 |
Check the financial reports for the company - Efarmacie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 26.127 | 24.876 | 20.142 | 6.635 | 6.340 | 6.603 | 5.657 | 5.752 | 5.300 | 10.147 |
| Current Assets | 159.057 | 162.025 | 77.905 | 89.988 | 103.426 | 107.530 | 146.942 | 125.998 | 111.137 | 115.816 |
| Inventories | 80.088 | 82.411 | 49.769 | 42.234 | 33.148 | 26.344 | 40.053 | 34.388 | 45.666 | 42.212 |
| Receivables | 78.706 | 29.439 | 27.352 | 46.835 | 69.786 | 79.732 | 97.399 | 82.171 | 56.685 | 60.433 |
| Cash | 263 | 50.176 | 784 | 920 | 492 | 1.455 | 9.490 | 9.439 | 8.785 | 13.170 |
| Shareholders Funds | 2.832 | 17.582 | 4.456 | -238 | 15.676 | 32.675 | 54.816 | 31.205 | 27.622 | 11.804 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 182.352 | 170.937 | 94.957 | 97.970 | 94.903 | 82.164 | 98.358 | 100.546 | 88.814 | 114.159 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Efarmacie S.r.l.